BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu CS, Wang W, Qiang X, Chen W, Lan X, Li J, Wang H. Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review. Cells 2021;10:2220. [PMID: 34571869 DOI: 10.3390/cells10092220] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Zhang J, Zhang L, Hu L, Tian J. Significant difference of differential expression pyroptosis-related genes and their correlations with infiltrated immune cells in sepsis. Front Cell Infect Microbiol 2022;12:1005392. [DOI: 10.3389/fcimb.2022.1005392] [Reference Citation Analysis]
2 Liu J, Liu Y, Wang Y, Kang R, Tang D. HMGB1 is a mediator of cuproptosis-related sterile inflammation. Front Cell Dev Biol 2022;10:996307. [DOI: 10.3389/fcell.2022.996307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Liu M, Zhou J, Yin R, Yin H, Ding Y, Ma F, Qian L. The HMGB1 (C106A) mutation inhibits IL-10-producing CD19hiFcγRIIbhi B cell expansion by suppressing STAT3 activation in mice. Front Immunol 2022;13:975551. [DOI: 10.3389/fimmu.2022.975551] [Reference Citation Analysis]
4 Andersson U, Yang H. HMGB1 is a critical molecule in the pathogenesis of Gram-negative sepsis. Journal of Intensive Medicine 2022;2:156-166. [DOI: 10.1016/j.jointm.2022.02.001] [Reference Citation Analysis]
5 Gaboriaud C, Lorvellec M, Rossi V, Dumestre-Pérard C, Thielens NM. Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse. Front Immunol 2022;13:869720. [PMID: 35572583 DOI: 10.3389/fimmu.2022.869720] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Qiang X, Li J, Zhu S, He M, Chen W, Al-Abed Y, Brenner M, Tracey KJ, Wang P, Wang H. Human Dermcidin Protects Mice Against Hepatic Ischemia-Reperfusion-Induced Local and Remote Inflammatory Injury. Front Immunol 2021;12:821154. [PMID: 35095926 DOI: 10.3389/fimmu.2021.821154] [Reference Citation Analysis]
7 Zhang X, Su C, Zhao S, Li J, Yu F. Combination therapy of Ulinastatin with Thrombomodulin alleviates endotoxin (LPS) - induced liver and kidney injury via inhibiting apoptosis, oxidative stress and HMGB1/TLR4/NF-κB pathway. Bioengineered 2022;13:2951-70. [PMID: 35148668 DOI: 10.1080/21655979.2021.2024686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]